Inhibikase Therapeutics Inc banner

Inhibikase Therapeutics Inc
NASDAQ:IKT

Watchlist Manager
Inhibikase Therapeutics Inc Logo
Inhibikase Therapeutics Inc
NASDAQ:IKT
Watchlist
Price: 1.99 USD -1% Market Closed
Market Cap: $262.7m

Wall St Price Targets

IKT Price Targets Summary
Inhibikase Therapeutics Inc

Wall Street analysts forecast IKT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IKT is 6.12 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.

Lowest Forecast
Price Target
3.03 USD
52% Upside
Average Forecast
Price Target
6.12 USD
208% Upside
Highest Forecast
Price Target
8.4 USD
322% Upside
Inhibikase Therapeutics Inc Competitors:
Price Targets
LVS
Las Vegas Sands Corp
32% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is IKT's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for IKT is 6.12 USD with a low forecast of 3.03 USD and a high forecast of 8.4 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett